Scientists use patients' own lung fluid cells to fight advanced cancer
NCT ID NCT07443020
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new treatment for people whose cancer has spread to the lining of the lungs (pleura) or who have mesothelioma. Doctors collect immune cells from the patient's own lung fluid, grow them in a lab, and then put them back into the chest through a tube along with a drug that boosts their activity. The goal is to see if this approach is safe and can shrink tumors or ease symptoms. The study involves about 10 participants and includes a short hospital stay.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AHN West Penn Hospital
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Abdominal chemotherapy after surgery may improve mesothelioma outcomes
- Experimental drug tazemetostat offered to patients with rare, aggressive tumors
- Lung fluid may replace biopsies for cancer testing
- New antibody-chemo combo shows promise for mesothelioma
- Scientists collect chest tumor samples to unlock secrets of cancer spread